Long-Term Cardiovascular Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Using an Institution Based Algorithm
- 10 October 2022
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 44 (2) , 367-380
Abstract
Cardiovascular involvement is a major cause of inpatient and intensive care unit morbidity related to Multisystem inflammatory syndrome in children (MIS-C). The objective of this study was to identify long-term cardiovascular manifestations of MIS-C. We included 80 consecutive patients admitted to the intensive care unit with MIS-C who were evaluated for a year in our follow-up clinic using an institution protocol. The outcome measures were cardiac biomarkers (troponin and BNP), electrocardiogram changes, echocardiographic findings cardiovascular magnetic resonance (CMR) and graded-exercise stress test (GXT) findings. The cohort included patients aged between 6 months and 17 years (median 9 years; 48.8% females). At the peak of the disease 81.3% had abnormal BNP and 58.8% had troponin leak which reduced to 33.8% and 18.8% respectively at discharge with complete normalization by 6 weeks post-discharge. At admission 33.8% had systolic dysfunction, which improved to 11.3% at discharge with complete resolution by 2 weeks. Coronary artery abnormalities were seen in 17.5% during the illness with complete resolution by 2 weeks post discharge except one (1.9%) with persistent giant aneurysm at 1 year-follow up. CMR was performed at 6 months in 23 patient and demonstrated 4 patients with persistent late gadolinium enhancement (17.4%). Normal exercise capacity with no ectopy was seen in the 31 qualifying patients that underwent a GXT. There is significant heterogeneity in the cardiovascular manifestations of MIS-C. Although majority of the cardiovascular manifestations resolve within 6 weeks, diastolic dysfunction, CAA and myocardial scar may persist in a small subset of patients warranting a structured long-term follow-up strategy.Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 PandemicCirculation, 2020
- Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case SeriesJournal of the Pediatric Infectious Diseases Society, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020
- ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patientsAnnals of Intensive Care, 2020
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and MyocarditisCirculation, 2015
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disordersHuman Mutation, 2008
- Normal Human Left and Right Ventricular and Left Atrial Dimensions Using Steady State Free Precession Magnetic Resonance ImagingJournal of Cardiovascular Magnetic Resonance, 2005
- Two-dimensional echocardiographic assessment of left ventricular volumes and ejection fraction in children.Circulation, 1982